| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNCE | Jounce Therapeutics, Inc. | Concentra Biosciences, LLC | 10% Owner | May 03, 2023 | Option Exercise | $9737.70 | 10,000 | 97,377,002 | 10,000 | May 05, 2023, 04:38 PM | |
| JNCE | Jounce Therapeutics, Inc. | TANG CAPITAL PARTNERS LP | 10% Owner | May 03, 2023 | Option Exercise | $20.18 | 5,310,087 | 107,182,163 | 10,000 | May 05, 2023, 04:37 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | Director | Apr 04, 2023 | Sale | $1.85 | 39,228 | 72,572 | 188,779 | Apr 06, 2023, 04:37 PM | |
| JNCE | Jounce Therapeutics, Inc. | TANG CAPITAL PARTNERS LP | 10% Owner | Mar 14, 2023 | Buy | $1.02 | 20,286 | 20,651 | 5,300,087 | Mar 14, 2023, 08:39 PM | |
| JNCE | Jounce Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC | 10% Owner | Mar 13, 2023 | Buy | $0.99 | 65,701 | 65,307 | 5,279,801 | Mar 14, 2023, 08:39 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 09, 2023 | Sale | $1.10 | 4,159 | 4,575 | 108,543 | Jan 11, 2023, 08:33 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 10, 2023 | Sale | $1.12 | 5,126 | 5,741 | 103,417 | Jan 11, 2023, 08:33 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 09, 2023 | Sale | $1.10 | 20,191 | 22,210 | 252,886 | Jan 11, 2023, 08:32 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 10, 2023 | Sale | $1.12 | 24,879 | 27,864 | 228,007 | Jan 11, 2023, 08:32 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 09, 2023 | Sale | $1.10 | 6,315 | 6,947 | 73,799 | Jan 11, 2023, 08:30 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 10, 2023 | Sale | $1.12 | 7,781 | 8,715 | 66,018 | Jan 11, 2023, 08:30 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Operating Officer | Jan 10, 2023 | Sale | $1.12 | 9,182 | 10,284 | 110,082 | Jan 11, 2023, 08:29 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Operating Officer | Jan 09, 2023 | Sale | $1.10 | 7,452 | 8,197 | 119,264 | Jan 11, 2023, 08:29 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 07, 2022 | Sale | $7.30 | 3,005 | 21,937 | 90,580 | Jan 11, 2022, 08:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 10, 2022 | Sale | $6.65 | 5,378 | 35,764 | 85,202 | Jan 11, 2022, 08:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 07, 2022 | Sale | $7.30 | 13,370 | 97,601 | 209,501 | Jan 11, 2022, 08:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 10, 2022 | Sale | $6.65 | 23,924 | 159,095 | 185,577 | Jan 11, 2022, 08:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 07, 2022 | Sale | $7.30 | 4,595 | 33,544 | 60,836 | Jan 11, 2022, 08:56 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 10, 2022 | Sale | $6.65 | 8,222 | 54,676 | 52,614 | Jan 11, 2022, 08:56 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 10, 2022 | Sale | $6.65 | 6,205 | 41,263 | 64,216 | Jan 11, 2022, 08:55 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 07, 2022 | Sale | $7.30 | 3,468 | 25,316 | 70,421 | Jan 11, 2022, 08:55 PM | |
| JNCE | Jounce Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Nov 12, 2021 | Sale | $8.38 | 1,900,000 | 15,922,000 | 1,148,780 | Nov 16, 2021, 07:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Apr 15, 2021 | Sale | $10.00 | 200 | 2,000 | 9,713 | Apr 16, 2021, 08:46 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Mar 29, 2021 | Option Exercise | $7.06 | 10,200 | 71,961 | 98,685 | Mar 31, 2021, 08:22 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Mar 30, 2021 | Option Exercise | $7.01 | 200 | 1,402 | 93,685 | Mar 31, 2021, 08:22 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Mar 31, 2021 | Option Exercise | $7.06 | 16,600 | 117,113 | 101,885 | Mar 31, 2021, 08:22 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Mar 15, 2021 | Sale | $12.80 | 200 | 2,560 | 9,913 | Mar 17, 2021, 09:15 PM | |
| JNCE | Jounce Therapeutics, Inc. | Third Rock Ventures II, L.P. | 10% Owner | Mar 01, 2021 | Sale | $11.75 | 1,450,000 | 17,037,500 | 7,750,349 | Mar 03, 2021, 06:00 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Feb 16, 2021 | Sale | $11.78 | 200 | 2,356 | 10,113 | Feb 18, 2021, 07:47 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 21, 2021 | Option Exercise | $6.27 | 67,036 | 420,316 | 173,889 | Jan 25, 2021, 05:38 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 22, 2021 | Option Exercise | $9.64 | 28,000 | 269,850 | 65,189 | Jan 25, 2021, 05:36 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 20, 2021 | Option Exercise | $8.02 | 13,000 | 104,195 | 77,835 | Jan 22, 2021, 06:40 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Jan 20, 2021 | Sale | $12.00 | 1,500 | 18,000 | 10,513 | Jan 22, 2021, 06:39 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Jan 21, 2021 | Sale | $11.11 | 200 | 2,222 | 10,313 | Jan 22, 2021, 06:39 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 20, 2021 | Sale | $7.82 | 39,702 | 310,415 | 69,382 | Jan 22, 2021, 06:35 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 21, 2021 | Option Exercise | $7.18 | 7,598 | 54,554 | 46,980 | Jan 22, 2021, 06:35 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 15, 2021 | Option Exercise | $4.51 | 60,000 | 270,600 | 170,371 | Jan 20, 2021, 08:38 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 19, 2021 | Option Exercise | $5.04 | 80,000 | 402,800 | 180,371 | Jan 20, 2021, 08:38 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 20, 2021 | Option Exercise | $6.26 | 32,964 | 206,355 | 156,853 | Jan 20, 2021, 08:38 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 07, 2021 | Sale | $6.76 | 2,452 | 16,576 | 74,181 | Jan 11, 2021, 06:21 AM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 08, 2021 | Sale | $7.00 | 2,846 | 19,922 | 71,335 | Jan 11, 2021, 06:21 AM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 07, 2021 | Sale | $6.76 | 10,183 | 68,837 | 152,187 | Jan 11, 2021, 06:21 AM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 08, 2021 | Sale | $7.00 | 11,816 | 82,712 | 140,371 | Jan 11, 2021, 06:21 AM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 07, 2021 | Sale | $6.76 | 2,697 | 18,232 | 59,011 | Jan 11, 2021, 06:19 AM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 08, 2021 | Sale | $7.00 | 3,130 | 21,910 | 55,881 | Jan 11, 2021, 06:19 AM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 08, 2021 | Sale | $7.00 | 3,340 | 23,380 | 55,189 | Jan 11, 2021, 06:19 AM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 07, 2021 | Sale | $6.76 | 2,879 | 19,462 | 58,529 | Jan 11, 2021, 06:19 AM | |
| JNCE | Jounce Therapeutics, Inc. | Third Rock Ventures GP II, L.P. | 10% Owner | Nov 19, 2020 | Sale | $7.01 | 15,000 | 105,075 | 9,200,349 | Nov 23, 2020, 04:42 PM | |
| JNCE | Jounce Therapeutics, Inc. | LEVIN MARK J | 10% Owner | Nov 17, 2020 | Sale | $7.25 | 15,000 | 108,773 | 9,215,349 | Nov 19, 2020, 05:42 PM | |
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Sep 15, 2020 | Sale | $7.11 | 20,000 | 142,100 | 10,000 | Sep 16, 2020, 06:43 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Sep 01, 2020 | Sale | $8.06 | 7,200 | 58,032 | 61,708 | Sep 02, 2020, 06:05 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 17, 2020 | Sale | $4.86 | 454 | 2,206 | 69,652 | Aug 18, 2020, 08:31 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 18, 2020 | Sale | $4.71 | 744 | 3,504 | 68,908 | Aug 18, 2020, 08:31 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 14, 2020 | Sale | $4.64 | 984 | 4,566 | 70,106 | Aug 18, 2020, 08:31 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Aug 14, 2020 | Sale | $4.67 | 1,728 | 8,070 | 77,831 | Aug 18, 2020, 08:30 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Aug 17, 2020 | Sale | $4.86 | 454 | 2,206 | 77,377 | Aug 18, 2020, 08:30 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 17, 2020 | Sale | $4.86 | 454 | 2,206 | 62,152 | Aug 18, 2020, 08:29 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 18, 2020 | Sale | $4.71 | 744 | 3,504 | 61,408 | Aug 18, 2020, 08:29 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 14, 2020 | Sale | $4.64 | 984 | 4,566 | 62,606 | Aug 18, 2020, 08:29 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Jan 07, 2020 | Sale | $7.78 | 2,624 | 20,415 | 44,390 | Jan 10, 2020, 08:54 AM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jan 07, 2020 | Sale | $7.78 | 2,624 | 20,415 | 56,565 | Jan 10, 2020, 08:54 AM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Jan 07, 2020 | Sale | $7.78 | 7,150 | 55,627 | 87,360 | Jan 10, 2020, 08:53 AM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jan 07, 2020 | Sale | $7.78 | 2,624 | 20,415 | 33,590 | Jan 10, 2020, 08:53 AM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Jan 06, 2020 | Sale | $8.11 | 1,500 | 12,165 | 12,013 | Jan 08, 2020, 04:56 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Dec 23, 2019 | Option Exercise | $4.42 | 80,000 | 354,000 | 134,510 | Dec 26, 2019, 05:08 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 14, 2019 | Sale | $4.10 | 670 | 2,747 | 37,880 | Aug 16, 2019, 09:00 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 15, 2019 | Sale | $4.00 | 648 | 2,592 | 37,232 | Aug 16, 2019, 09:00 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Aug 16, 2019 | Sale | $3.92 | 1,018 | 3,991 | 36,214 | Aug 16, 2019, 09:00 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Aug 16, 2019 | Sale | $3.92 | 1,018 | 3,991 | 59,189 | Aug 16, 2019, 08:59 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Aug 14, 2019 | Sale | $4.10 | 670 | 2,747 | 60,855 | Aug 16, 2019, 08:59 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Aug 15, 2019 | Sale | $4.00 | 648 | 2,592 | 60,207 | Aug 16, 2019, 08:59 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 14, 2019 | Sale | $4.10 | 670 | 2,747 | 48,680 | Aug 16, 2019, 08:58 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 15, 2019 | Sale | $4.00 | 648 | 2,592 | 48,032 | Aug 16, 2019, 08:58 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 16, 2019 | Sale | $3.92 | 1,018 | 3,991 | 47,014 | Aug 16, 2019, 08:58 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Sep 06, 2018 | Option Exercise | $0.48 | 32,000 | 15,360 | 32,000 | Sep 07, 2018, 04:48 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Aug 27, 2018 | Option Exercise | $2.36 | 12,700 | 29,972 | 27,100 | Aug 28, 2018, 05:28 PM | |
| JNCE | Jounce Therapeutics, Inc. | Cole Hugh M | Chief Business Officer | Jun 15, 2018 | Buy | $7.84 | 1,900 | 14,896 | 1,900 | Jun 18, 2018, 06:24 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Jun 08, 2018 | Option Exercise | $4.02 | 24,875 | 99,997 | 24,875 | Jun 12, 2018, 06:01 PM | |
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Mar 15, 2018 | Option Exercise | $16.16 | 4,000 | 64,640 | 2,000 | Mar 19, 2018, 06:42 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Mar 08, 2018 | Option Exercise | $14.54 | 9,090 | 132,169 | 4,545 | Mar 12, 2018, 07:07 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Mar 08, 2018 | Option Exercise | $12.79 | 32,668 | 417,824 | 16,334 | Mar 12, 2018, 07:06 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Mar 08, 2018 | Option Exercise | $14.79 | 9,026 | 133,532 | 5,267 | Mar 12, 2018, 07:06 PM | |
| JNCE | Jounce Therapeutics, Inc. | Trehu Elizabeth | Chief Medical Officer | Mar 05, 2018 | Sale | $12.76 | 9,090 | 115,995 | 4,545 | Mar 07, 2018, 07:00 PM | |
| JNCE | Jounce Therapeutics, Inc. | MURRAY RICHARD /CA/ | CEO and President | Mar 05, 2018 | Sale | $10.96 | 32,668 | 357,883 | 16,334 | Mar 07, 2018, 06:59 PM | |
| JNCE | Jounce Therapeutics, Inc. | Drapkin Kimberlee C | CFO and Treasurer | Mar 05, 2018 | Sale | $21.42 | 5,267 | 112,803 | 2,775 | Mar 07, 2018, 06:57 PM | |
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Jan 26, 2018 | Sale | $14.61 | 8,000 | 116,840 | 4,000 | Jan 29, 2018, 08:26 PM | |
| JNCE | Jounce Therapeutics, Inc. | KARSEN PERRY A | Director | Feb 01, 2017 | Buy | $16.00 | 5,000 | 80,000 | 5,000 | Feb 02, 2017, 05:03 PM | |
| JNCE | Jounce Therapeutics, Inc. | Higgons John Duncan | Director | Feb 01, 2017 | Buy | $16.00 | 6,700 | 107,200 | 27,025 | Feb 02, 2017, 05:03 PM | |
| JNCE | Jounce Therapeutics, Inc. | CELGENE CORP /DE/ | 10% Owner | Feb 01, 2017 | Buy | $16.00 | 625,000 | 10,000,000 | 3,456,463 | Feb 01, 2017, 04:18 PM |
Menu